Texray AB | Gothenburg, Sweden | June 6, 2013 |

Sweden is dependent on new, innovative development-based companies, which can become future growth companies. Interest from private financing of early-stage companies is usually low as it involves high-risk investments.

Vinnova has established several funds for start-ups and early-stage companies: VINN-NU is one of the programs. 150 companies applied, 15 companies were selected, and three of them were life science companies. One of them was Ten Medical Design (10MD) in Gothenburg.

“With the help of this highly prestigious fund from Vinnova, we will continue our strategic plan towards commercializing a new material for radiation safety protection products,” says Fredrik Gellerstedt, one of the founders of 10MD.

Vinnova press release, 2013-06-17

Life Science Sweden, press release, 2013-06-18

GöteborgBIO, press release, 2013-06-24

Innovationskontor Väst, Chalmers University of Technology, 2013-06-24